Heart Disease, Pregnancy and Systemic Autoimmune Diseases

Heart Disease in Pregnancy: Second Edition

Volumn , Issue , 2007, Pages 136-150

  Ruiz Irastorza, Guillermo ^a   Khamashta, Munther A ^b   Hughes, Graham Rv ^b,c  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c LONDON BRIDGE HOSPITAL   (United Kingdom)

Author keywords

Heart disease; Inflammatory myopathies; Pregnancy; Systemic autoimmune diseases; Systemic sclerosis

Indexed keywords

EID: 44849098246     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470994955.ch11     Document Type: Chapter

References (83)

1. Cervera R, Khamashta MA, Font J et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1000 patients. Medicine (Baltimore) 1999;78:167-75.
2. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
3. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
4. Hughes GRV. Is it lupus? The St. Thomas' Hospital 'alternative' criteria. Clin Exp Rheumatol 1998;16:250-2.
5. Ruiz-Irastorza G, Khamashta MA, Nelson-Piercy C, Hughes GRV. Effects of lupus and antiphospholipid syndrome on pregnancy. Yearbook Obstet Gynaecol 2002;10:105-19.
6. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993;342:341-4.
7. Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus 2005;14:683-6.
8. Lockshin M, Tenedios F, Petri M et al. Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report. Lupus 2003;12:518-23.
9. Tenedios F, Erkan D, Lockshin MD. Cardiac involvement in the antiphospholipid syndrome. Lupus 2005;14:691-6.
10. Berkun Y, Elami A, Meir K, Mevorach D, Naparstek Y. Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery. J Thorac Cardiovasc Surg 2004;127:414-20.
11. Manzi S, Meilhn EN, Rairie JE et al. Age specific incidence rates of myocardial infarction and angina in women with SLE: comparison with the Framingham study. Am J Epidemiol 1997;145:408-15.
12. Roman MJ, Shanker BA, Davis A et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-406.
13. Ruiz-Irastorza G, Khamashta MA, Hunt BJ, Escudero A, Cuadrado MJ, Hughes GRV. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target INR of 3.5. Arch Intern Med 2002;162:1164-9.
14. Erkan D, Yazici Y, Peterson MG, Sammaritano L, Lockshin MD. A cross-section study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology 2002;41:924-9.
15. McGoon M, Gutterman D, Steen V et al. Screening, early detection and diagnosis of pulmonary arterial hypertension. ACCP evidence-based clinical practice guidelines. Chest 2004;126:14S-34S.
16. Li EK, Tam LS. Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients. J Rheumatol 1999;26:1923-9.
17. Asherson RA, Higenbottam TW, Xuan ATD, Khamashta MA, Hughes GRV. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 1990;17:1292-8.
18. Brucato A, Frassi M, Franceschini F et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001;44:1832-5.
19. Buyon JP, Kim MY, Copel JA, Friedman DM. Anti-Ro/SSA antibodies and congenital heart block: necessary but not sufficient. Arthritis Rheum 2001;44:1723-7.
20. Tseng CE, Buyon JP. Neonatal lupus syndromes. Rheum Dis Clin North Am 1997;23:31-54.
21. Wigley FM, Hummers LK. Clinical features of systemic sclerosis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds), Rheumatology, 3rd edn. Edinburgh: Mosby, 2003: pp 1463-79.
22. Ferri C, Giuggioli D, Sebastiani M, Colaci M, Emdin M. Heart involvement in systemic sclerosis. Lupus 2005;14:702-7.
23. Denton CP, Cailes JB, Phillips GD, Wells AU, Black CM, Du Bois RM. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol 1997;36:239-43.
24. Ferri C, Valentini G, Cozzi F et al. Systemic sclerosis. Demographic, clinical and serological features and survival in 1012 Italian patients. Medicine 2002;81:139-53.
25. Oddis CV, Medsger TA Jr. Inflammatory muscle disease: clinical features. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds), Rheumatology, 3rd edn. Edinburgh: Mosby, 2003: pp 1537-54.
26. Lundberg IE. Cardiac involvement in autoimmune myositis and mixed connective tissue disease. Lupus 2005;14:708-12.
27. Bull TM, Fagan KA, Badesch DB. Pulmonary vascular manifestations of mixed connective tissue disease. Rheum Dis Clin N Am 2005;31:451-64.
28. Savage CO, Harper L, Cockwell DA, Howie AJ. Vasculitis. BMJ 2000;320:1325-8.
29. Pagnoux C, Guillevin L. Cardiac involvement in small and medium-sized vessel vasculitis. Lupus 2005;14:718-22.
30. Marshall S. Behçet disease. Best Pract Res Clin Rheumatol 2004;18:291-311.
31. Atzeni F, Sarzi-Puttini P, Doria A, Boiardi L, Pipitone N, Salvarini C. Behçet disease and cardiovascular involvement. Lupus 2005;14:723-6.
32. Ruiz-Irastorza G, Khamashta MA. Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Ann N Y Acad Sci 2005; 1051:606-12.
33. Ruiz-Irastorza G, Khamashta MA, Nelson-Piercy C, Hughes GR. Lupus pregnancy: is heparin a risk factor for osteoporosis? Lupus 2001;10:597-600.
34. Ruiz-Irastorza G, Khamashta MA. Evaluation of systemic lupus erythematosus activity during pregnancy. Lupus 2004;13:679-82.
35. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991;34:1538-45.
36. Ruiz-Irastorza G, Lima F, Alves J et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol 1996;35:133-8.
37. Steen VD, Conte C, Day N, Ramsey-Goldman R, Medsger TA. Pregnancy in women with systemic sclerosis. Arthritis Rheum 1989;32:151-7.
38. Steen VD, Brodeur M, Conte C. Prospective pregnancy study in women with systemic sclerosis (SSc). Arthritis Rheum 1996;39:S151.
39. Steen VD. Scleroderma and pregnancy. Rheum Dis Clin North Am 1997;23:133-47.
40. Silva CA, Sultan SM, Isenberg DA. Pregnancy outcome in adult-onset idiopathic inflammatory myopathy. Rheumatology (Oxford) 2003;42:1168-72.
41. Kitridou RC. Pregnancy in mixed connective tissue disease. Rheum Dis Clin N Am 2005;31:497-508.
42. Gordon C. Pregnancy and autoimmune disease. Best Pract Res Clin Rheumatol 2004;18:359-79.
43. Lima F, Buchanan NMM, Froes L, Kerslake S, Khamashta MA, Hughes GRV. Pregnancy in granulomatous vasculitis. Ann Rheum Dis 1995;54:604-6.
44. Sharma BK, Jain S, Vasishta K. Outcome of pregnancy in Takayasu arteritis. Int J Cardiol 2000;75:S159-62.
45. Marsal S, Falga C, Simeon CP, Vilardell M, Bosch JA. Behçet disease and pregnancy relationship study. Br J Rheumatol 1997;36:234-8.
46. Buyon JP, Rupel A, Clancy RM. Neonatal lupus syndromes. Lupus 2004;13:705-12.
47. Saaleb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block. Arthritis Rheum 1999;42:2335-45.
48. Whitelaw A, Thoresen M. Antenatal steroids and the developing brain. Arch Dis Child Neonatal 2000;83:F154-7.
49. Baud O, Foix-L'Helias L, Kamisnski M et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999;341:1190-6.
50. Hughes G. The eradication of congenital heart block. Lupus 2004;13:489.
51. Simonneau G, Galie N, Rubin L et al. Clinical classification of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:S5-S12.
52. Galie N, Manes A, Farahani KV et al. Pulmonary arterial hypertension associated to connective tissue diseases. Lupus 2005;14:713-17.
53. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004;351:1425-36.
54. Monnery L, Nanson J, Charlton G. Primary pulmonary hypertension in pregnancy: a role for novel vasodilators. Br J Anaesth 2001;87:295-8.
55. Lupton M, Oteng-Ntim E, Ayida G, Steer PJ. Cardiac disease in pregnancy. Curr Opin Obstet Gynecol 2002;14:137-43.
56. Decoene C, Bourzoufi K, Moreau D, Narducci F, Crepin F, Krivosic-Horber R. Use of inhaled nitric oxide for emergency cesarean section in a woman with unexpected primary pulmonary hypertension. Can J Anaesth 2001;48:584-7.
57. Lam GK, Stafford RE, Thorp J, Moise KJ Jr, Cairns BA. Inhaled nitric oxide for primary pulmonary hypertension in pregnancy. Obstet Gynecol 2001;98:895-8.
58. Bildirici I, Shumway JB. Intravenous and inhaled epoprostenol for primary pulmonary hypertension during pregnancy. Am J Obstet Gynecol 2004;103:1102-5.
59. Bonnin M, Mercier FJ, Sitbob O et al. Severe pulmonary hypertension during pregnancy. Mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 2005;102:1133-7.
60. McMillan E, Martin WL, Waugh J et al. Management of pregnancy in women with pulmonary hypertension secondary to SLE and anti-phospholipid syndrome. Lupus 2002;11:392-8.
61. Milne F, Redman C, Walker J et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ 2005;330:576-80.
62. Johnson MJ. Obstetric complications and rheumatic disease. Rheum Dis Clin North Am 1997;23:169-82.
63. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005;330:565.
64. Stone S, Khamashta MA, Poston L. Placentation, antiphospholipid syndrome and pregnancy outcome. Lupus 2001;10:67-74.
65. Dekker GA, De Vries JI, Doelitzsch PM et al. Underlying disorders associated with severe early onset pre-eclampsia. Am J Obstet Gynecol 1995;173:1042-8.
66. Petri M. Hopkins Lupus Pregnancy Center: 1987 to 1996. Rheum Dis Clin North Am 1997;23:1-13.
67. Ornstein MH, Rand JH. An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy: a report of 2 cases. J Rheumatol 1994;21:1360-4.
68. Packham DK, Lam SS, Nichols K et al. Lupus nephritis and pregnancy. Q J Med 1992;83:315-24.
69. Nelson-Piercy C. Hypertension and pre-eclampsia. In: Nelson-Piercy C (ed.), Handbook of Obstetric Medicine. Isis Medical Media, Oxford, 1997: pp 1-16.
70. Papageorghiou AT, Roberts N. Uterine artery Doppler screening for adverse pregnancy outcome. Curr Op Obstet Gynecol 2005;17:584-90.
71. Duley L, Henderson-Smart D, Knight M, King J. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. BMJ 2001;322:329-33.
72. Bazaan M, Donvito V. Low-molecular-weight heparin during pregnancy. Thromb Res 2001;101:V175-86.
73. Ruiz-Irastorza G, Khamashta MA, Hughes GRV. Hughes syndrome crosses boundaries. Autoimmun Rev 2002;1:43-8.
74. Cuadrado MJ, Mendonça LLF, Khamashta MA et al. Maternal and fetal outcome in antiphospholipid syndrome pregnancies with a history of previous cerebral ischemia (abstract). Arthritis Rheum 1999;42:S265.
75. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-7.
76. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992;117:303-8.
77. Schulman S, Svenungsson E, Granqvist S and the Duration of Anticoagulation Study Group. Anticardiolipin antibodies predict early recurrence in thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Am J Med 1998;104:332-8.
78. Kearon C, Gent M, Hirsh J et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999;340:901-7.
79. Derksen RHWM, Khamashta MA, Branch DW. Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 2004;50:1028-39.
80. Ruiz-Irastorza G, Khamashta MA, Hughes GRV. Treatment of pregnancy loss in Hughes syndrome: a critical update. Autoimmunity Rev 2002;1:298-304.
81. Bates S, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126:627S-44S.
82. Lupton M, Oteng-Ntim E, Ayida G, Steer PJ. Cardiac disease in pregnancy. Curr Opin Obstet Gynecol 2002;14:137-43.
83. Wetzl RG. Anesthesiological aspects of pregnancy in patients with rheumatic diseases. Lupus 2004;13:699-702.